Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00681655 · ClinicalTrials.gov registry record · NA
GABRA2 and the Pharmacokinetics of Risk for Alcoholism (GPRA)
A NA study, sponsored by Indiana University.
- Completed
- Registry status
- NA
- Development phase
- 141
- Enrollment target
NCT00681655: Completed NA study, sponsored by Indiana University.
NCT00681655 is a NA study that has completed, run by Indiana University. The registered enrollment target is 141 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00681655, a NA study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- NA
- Development phase
- 141 participants
- Enrollment target
Study Summary
This study will assess whether the presence of a particular form of a gene, GABRA2, affects the functional responses of the human brain to alcohol administration and will evaluate that relationship in the context of factors known to increase the risk for future alcoholism.
Primary Outcome
Results will assess the effect of GABRA2 SNPs on responses to alcohol and traits related to alcoholism risk
Interventions
- OTHER Placebo
- OTHER Alcohol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 141 participants |
| Start Date | 2008-05 |
| Est. Completion | 2012-04-14 |
| Phase | NA |
What the finished NCT00681655 record still lists
NCT00681655 is an interventional study that assigns participants to a tested intervention. The registered 141 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00681655 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00681655 about?
NCT00681655 is a clinical study titled "GABRA2 and the Pharmacokinetics of Risk for Alcoholism (GPRA)". This study will assess whether the presence of a particular form of a gene, GABRA2, affects the functional responses of the human brain to alcohol administration and will evaluate that relationship in the context of factors known to increase the risk for future alcoholism.
What is the current status of trial NCT00681655?
This trial is currently completed. It is a NA study. The enrollment target is 141 participants. The study started on 2008-05. Estimated completion is 2012-04-14.
What interventions are being tested in trial NCT00681655?
The interventions under investigation include: Placebo (OTHER), Alcohol (OTHER).
Who is sponsoring clinical trial NCT00681655?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00681655's enrollment target sits among peer trials
141 712th of 2000 higher than 1,288 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03042962 · 141 participants
Brain Networks in Dystonia
- NCT04378439 · 141 participants · NA
Appalachian Partnership to Reduce Disparities (Aim 2)
- NCT04775485 · 141 participants · Phase 2
A Study to Evaluate Tovorafenib in Pediatric and Young Adult Participants With Relapsed or Progressive Low-Grade Glioma and Advance Solid Tumors
- NCT05040360 · 141 participants · Phase 2
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia